|
|
| (115 intermediate revisions by 5 users not shown) |
| Line 1: |
Line 1: |
| ==Bone and Joint==
| | {{Antibiotics by diagnosis navigation}} |
|
| |
|
| ==Cardiovascular==
| | ==See Also== |
| | |
| ==CNS==
| |
| | |
| ==ENT==
| |
| | |
| ==Eye==
| |
| | |
| ==GI==
| |
| | |
| ==GU==
| |
| | |
| ==Pulmonary==
| |
| | |
| ==Skin and Soft Tissue==
| |
| | |
| ==Bioterrorism==
| |
| | |
| ==Environmental Exposure==
| |
| | |
| ==Immunocompromised==
| |
| | |
| ==Post Exposure Prophylaxis==
| |
| | |
| ==Pediatric==
| |
| | |
| ==Sepsis==
| |
| | |
| ==Arthropod and Parasitic Infections==
| |
| | |
| {| cellspacing="0" cellpadding="2" border="1" align="left" style="width: 483px; height: 2459px;"
| |
| |-
| |
| | '''Diagnosis'''<br>
| |
| | '''Commonly Used Antibiotic(s)'''<br>
| |
| |-
| |
| | [[Meningitis]]<br>
| |
| |
| |
| Vancomycin 750mg (15mg/kg) IV
| |
| | |
| ''PLUS''
| |
| | |
| Ceftriaxone 2g (50mg/kg) IV
| |
| | |
| ''ADD''
| |
| | |
| Ampicillin 2g (50mg/kg) IV ''if concern for Listeria''
| |
| | |
| |-
| |
| | [[Otitis Media (Peds)|Otitis Media]]<br>
| |
| |
| |
| Amoxicillin 500mg (45mg/kg) PO Q12
| |
| | |
| ''OR''
| |
| | |
| Augmentin 500mg (45mg/kg) PO Q12
| |
| | |
| ''OR''
| |
| | |
| Cefdinir 600mg (14mg/kg) PO Daily
| |
| | |
| |-
| |
| | [[Otitis Externa]]<br>
| |
| |
| |
| Ciprodex 3gtt Q12
| |
| | |
| ''OR''
| |
| | |
| Polysporin otic 5gtt Q6
| |
| | |
| |-
| |
| | [[Pharyngitis]]
| |
| |
| |
| Bicillin 1.2 million units (25k/kg) IM
| |
| | |
| ''OR''
| |
| | |
| Azithromycin 500mg (12mg/kg) PO Daily
| |
| | |
| |-
| |
| | [[Corneal Abrasion]]<br>
| |
| |
| |
| Erythromycin ophthalmic Q6
| |
| | |
| ''OR''
| |
| | |
| Levofloxacin 0.5% 2gtt Q2 ''if patient is a contact user''
| |
| | |
| |-
| |
| | [[Orbital Cellulitis]]<br>
| |
| | Vancomycin 1g (15mg/kg) IV Q12<br>
| |
| |-
| |
| | [[Appendicitis]]
| |
| |
| |
| Zosyn 4.5g (100 mg/kg) IV Q6
| |
| | |
| ''OR''
| |
| | |
| Flagyl 500mg (7.5mg/kg) IV Q6
| |
| | |
| ''PLUS''
| |
| | |
| Ciprofloxacin 400mg IV Q12
| |
| | |
| |-
| |
| | [[Cholecystitis]]<br>
| |
| |
| |
| Augmentin 3g IV Q6
| |
| | |
| ''OR''
| |
| | |
| Imipenem/Cilastin 500mg IV Q6
| |
| | |
| |-
| |
| | [[Diverticulitis]]
| |
| |
| |
| Flagyl 500mg PO Q6
| |
| | |
| ''PLUS''
| |
| | |
| Ciprofloxacin 750mg PO Q12
| |
| | |
| |-
| |
| | Infectious [[Diarrhea]]
| |
| |
| |
| Empiric: Cipro 500mg PO Q12 x3d
| |
| | |
| Giardia: Flagyl 500mg PO Q8 x5d
| |
| | |
| C. diff: Flagyl 500mg PO Q8 x14d
| |
| | |
| |-
| |
| | [[Epididymitis]]
| |
| |
| |
| Age <35 (gonorrhea suspected):
| |
| | |
| Doxycycline 100mg PO Q12 x14d
| |
| | |
| ''PLUS''
| |
| | |
| Cefixime 400mg PO once
| |
| | |
| Age >35 (gonorrhea not suspected):
| |
| | |
| Ciprofloxacin 500mg PO Q12 x14d
| |
| | |
| |-
| |
| | [[Cervicitis]]/[[Urethritis]]
| |
| |
| |
| Cefixime 400mg PO once
| |
| | |
| ''OR''
| |
| | |
| Azithromycin 1g PO once
| |
| | |
| ''ADD''
| |
| | |
| Flagyl 2g PO once ''if concern for trichomoniasis''
| |
| | |
| |-
| |
| | [[PID]]<br>
| |
| |
| |
| Ceftriaxone 250mg 1M once
| |
| | |
| ''PLUS''
| |
| | |
| Doxycycline 100 mg PO Q12 x14d
| |
| | |
| |-
| |
| | [[UTI]]
| |
| |
| |
| Macrobid 100mg PO BID x7d
| |
| | |
| ''OR''
| |
| | |
| Bactrim DS PO Q12 x3d
| |
| | |
| ''OR''
| |
| | |
| Keflex 500mg PO Q6 x7d
| |
| | |
| |-
| |
| | [[Pneumonia]]<br>
| |
| |
| |
| Outpatient:
| |
| | |
| Azithromycin 500mg PO, 250mg PO x3d
| |
| | |
| ''OR''
| |
| | |
| Doxycycline 100mg PO Q12 x7d
| |
| | |
| Inpatient, Community Acquired
| |
| | |
| Ceftriaxone 1g IV
| |
| | |
| ''PLUS''
| |
| | |
| Azithromycin 500mg IV
| |
| | |
| Inpatient, Health Care Acquired
| |
| | |
| Vancomycin 1g IV ''(MRSA)''
| |
| | |
| ''PLUS''
| |
| | |
| Cefepime 2g IV ''(Pseudomonas)''
| |
| | |
| ''PLUS''
| |
| | |
| Tobramycin 4mg/kg IV ''(Pseudomonas)''
| |
| | |
| |-
| |
| | [[Cellulitis]]/Superficial [[Abscess]]
| |
| |
| |
| Bactrim DS 2tab PO Q12 x5-10d
| |
| | |
| ''PLUS''
| |
| | |
| [[Cephalexin]] 500mg PO Q6 x5-10
| |
| | |
| ''OR''
| |
| | |
| Clindamycin 450mg PO Q8 x5-10d
| |
| | |
| Diabetic with systemic toxicity
| |
| | |
| Vancomycin 1g IV
| |
| | |
| ''PLUS''
| |
| | |
| Unasyn 3g IV
| |
| | |
| ''OR''
| |
| | |
| Zosyn 3.375g IV
| |
| | |
| |-
| |
| | [[Neutropenic Fever]]
| |
| |
| |
| Zosyn 4.5g IV
| |
| | |
| ''OR''
| |
| | |
| Meropenem 1g IV
| |
| | |
| ''PLUS/MINUS''
| |
| | |
| Gentamicin 2mg/kg IV
| |
| | |
| ''ADD''
| |
| | |
| Vancomycin 1g IV ''for catheter related infection, colonization with MRSA, gram-positive culture unknown susceptibility, suspected sepsis''
| |
| | |
| |}
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| <br>
| |
| | |
| == See Also == | |
| *[[Antibiotics (Main)]] | | *[[Antibiotics (Main)]] |
| *[[Initial Antibiotics in Sepsis]] | | *[[Antibiotics by organism]] |
| | |
| == Source ==
| |
| *CURRENT Medical Dx & Tx
| |
| *University of Cincinnati Department of Emergency Medicine "Handbook of EM Fundamentals"
| |
|
| |
|
| [[Category:ID]] [[Category:Drugs]] | | ==References== |
| | <references/> |
| | [[Category:ID]] [[Category:Pharmacology]] |
